Haematology: Involved-site radiotherapy: Hodgkin consolidation dose
Free question published 03 November 2026
A 26-year-old man with classical Hodgkin lymphoma is to receive consolidation involved-site radiotherapy after chemotherapy for a chemosensitive residual mediastinal mass. The prescribing registrar asks what conventional consolidation dose is typically used for chemosensitive classical Hodgkin lymphoma. Which dose is most appropriate?
- A4 Gy in 2 fractions
- B8 Gy in a single fraction
- C50 to 54 Gy in 25 to 27 fractions
- D60 Gy in 30 fractions
- E20 to 30 Gy in 1.8 to 2 Gy fractions
Why E is correct
Modern consolidation radiotherapy for chemosensitive classical Hodgkin lymphoma is delivered as involved-site radiotherapy to a reduced volume at modest doses, typically in the region of 20 to 30 Gy in conventional 1.8 to 2 Gy fractions, reflecting de-escalation from historical higher-dose extended-field techniques while maintaining local control.
And why the others are not
- AIncorrect: 4 Gy in 2 fractions is the low-dose palliative schedule for indolent lymphoma, not curative Hodgkin consolidation.
- BIncorrect: 8 Gy single fraction is a palliative bone schedule, not Hodgkin consolidation.
- CIncorrect: 50 to 54 Gy is the definitive primary radiotherapy dose for NK/T-cell nasal lymphoma, far higher than needed for chemosensitive Hodgkin consolidation.
- DIncorrect: 60 Gy reflects obsolete high-dose practice and is excessive and toxic for chemosensitive Hodgkin disease.
Source NCI PDQ - Hodgkin lymphoma combined-modality radiotherapy consolidation dose — PDQ Adult Treatment Editorial Board. Adult Hodgkin Lymphoma Treatment (PDQ): Health Professional Version. Bethesda, MD: National Cancer Institute. Updated 2024.
More free haematology questions
Sitting in February? Follow the twenty-week plan.
2,500+ cited questions like this one are waiting in the vault.
See plans and pricing